Skip to main content

and
  1. Article

    Open Access

    Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome

    Vaccine development is essential for pandemic preparedness. We previously conducted a Phase 1 clinical trial of the vector vaccine candidate MVA-MERS-S against the Middle East respiratory syndrome coronavirus ...

    Anahita Fathi, Christine Dahlke, Verena Krähling, Alexandra Kupke in Nature Communications (2022)

  2. Article

    Open Access

    Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza

    While several studies have described the clinical course of patients with coronavirus disease 2019 (COVID-19), direct comparisons with patients with seasonal influenza are scarce. We compared 166 patients with...

    Thomas Theo Brehm, Marc van der Meirschen, Annette Hennigs in Scientific Reports (2021)

  3. Article

    Unique human immune signature of Ebola virus disease in Guinea

    Fatal Ebola virus disease is characterized by a high proportion of CD4+ and CD8+ T cells expressing the inhibitory molecules CTLA-4 and PD-1, correlating with high virus load; individuals who survive the infectio...

    Paula Ruibal, Lisa Oestereich, Anja Lüdtke, Beate Becker-Ziaja, David M. Wozniak in Nature (2016)